Top Markets
Coin of the day
BioNexus Gene Lab Corp. BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp.

BGLC
Pozycja w akcjach #35594
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala... BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Cena akcji
$1.50
Ostatnia synchronizacja: 2026-09-21
Kapitalizacja rynkowa
$3.63M
Zmiana (1 dzień)
-4.46%
Zmiana (1 rok)
-72.68%
Kraj
MY
Handel BioNexus Gene Lab Corp. (BGLC)

Kategoria

EPS dla BioNexus Gene Lab Corp. (BGLC)
EPS na dzień June 2026 TTM: $-1.26
Według najnowszych raportów finansowych i ceny akcji firmy BioNexus Gene Lab Corp., obecny EPS (TTM) wynosi $-1.26. Na koniec roku 2023 firma miała EPS w wysokości $-1.53, wzrost w porównaniu do do EPS z roku 2022, który wynosił $-0.25.
Historia EPS dla BioNexus Gene Lab Corp. od 2016 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
2026 (TTM) $-1.26 40.00%
2024 $-0.90 -41.18%
2023 $-1.53 512.00%
2022 $-0.25 -147.17%
2021 $0.53 -58.59%
2020 $1.28 -3,842.69%
2019 $-0.03 -812.50%
2018 0.00 -124.12%
2017 $-0.02 19,800.00%
2016 0.00 0.00%
EPS dla podobnych firm lub konkurentów
Firma EPS Różnica w EPS Kraj
$39.24 -3,214.29%
US
$1.18 -193.65%
US
- -
US
$14.65 -1,262.70%
US
- -
US